so our adjusted earnings per share grew to $num-one in the quarter, up num-two% over qtr-three year-five.
we now expect recurring revenue growth of num-one% to num-two% and adjusted earnings per share growth of num-three% to num-four%.
fast forward nine months, and we are poised to deliver num-one% to num-two% recurring revenue growth, driven by a combination of strong new sales and healthy financial markets.
as a result of that strong organic growth and an increase in our outlook for the fourth quarter, we're raising our guidance for recurring revenue growth to num-one% to num-two% for the full year, up from our prior guidance of growth at the higher end of num-three% to num-four%.
we are raising our outlook for fiscal year-six recurring revenue growth to num-one% to num-two% from the higher end of num-three% to num-four%, and that includes one point of growth from itiviti.
we are raising our guidance for total revenue growth to num-one% to num-two% from the higher end of num-three% to num-four%.
we are on track to deliver strong num-one% to num-two% recurring revenue growth.
we now expect recurring revenue growth of num-one% to num-two% and adjusted earnings per share growth of num-three% to num-four%.
and yet even after those investments and the near-term dilution from itiviti, we're positioned to deliver num-one% to num-two% adjusted earnings per share growth.
we expect adjusted earnings per share growth of num-one% to num-two%, up from the higher end of num-three% to num-four%, and that includes a num-txtoint drag from itiviti.